NYKODE THERAPEUTICS ASA financial statements, including revenue, expenses, profit, and loss

The total revenue of 5VB for the last quarter is 511.25 k EUR, and it's 31.39% lower compared to the previous quarter. The net income of Q2 24 is -6.94 M EUR.